Stockholm (HedgeNordic) – Swedish asset manager Coeli Asset Management has announced the liquidation of Coeli Multi Asset after learning of a major investor’s intention to...
Keep Reading →
March 2 - Hedge Funds, Insider Trading - Comments
Below we present the list of the top 5 healthcare stocks the experts at Sphera Global Healthcare Fund are buying.
Keep Reading →
February 20 - Hedge Funds, News - Comments
Billionaire Leon Cooperman told CNBC on Wednesday he believes rich people would find ways to avoid paying Sen. Elizabeth Warren’s wealth tax if it were to become law.
Keep Reading →
March 3 - Hedge Funds, Insider Trading - Comments
Below we present the list of Top 5 Large-Cap Healthcare Stocks to Buy Now.
Keep Reading →
February 6 - Hedge Fund Analysis, Hedge Funds, News - Comments
In this article we’ll check out the Top 5 Stocks Warren Buffett Just Bought.
Keep Reading →
November 27 - Hedge Fund Analysis, Hedge Funds, News - Comments
BOSTON (Reuters) - An activist investor is stepping up calls for the board of HC2 Holdings Inc (HCHC.N) to remove Chief Executive and Chairman Philip Falcone as the former hedge...
Keep Reading →
March 30 - Hedge Funds, Insider Trading - Comments
In a message he wrote shortly before his death, the legendary oil magnate T.
Keep Reading →
September 20 - Hedge Funds, Insider Trading - Comments
Elliott Management Corp. had built a position in Allergan Plc and was pushing to split the company before AbbVie Inc.
Keep Reading →
June 26 - Hedge Funds, Insider Trading - Comments
Numerous billionaire money managers, including the likes of Warren Buffett and Ken Fisher, absolutely love dividend stocks (check out a list of Ken Fisher's favorite dividend ...
Keep Reading →
December 7 - Dividend Stocks, Hedge Funds, News - Comments
Although billionaire superinvestor George Soros may no longer be running the day-to-day operations of his namesake fund "Soros Fund Management," the fund's quarterly activity ...
Keep Reading →
December 3 - Hedge Funds, Insider Trading - Comments
Omeros Corp. OMER, +36.60% shares surged 45% in extremely heavy morning trade Thursday on a new government spending bill that benefits its cataract surgery drug Omidria.
Keep Reading →
March 22 - Market Movers, News - Comments
Billionaire Paul Singer’s Elliott Management Corp. has bought a stake in Wipro Ltd., its first ever purchase of an Indian-based software outsourcer.
Keep Reading →
March 12 - Hedge Funds, Insider Trading - Comments
There is no doubt that the marijuana industry in the US has a lot of growth potential.
Keep Reading →
February 22 - Commodities, Hedge Funds, News - Comments
Shares of Devon Energy Corp.
Keep Reading →
February 21 - Market Movers, News - Comments
AbbVie, the maker of the world's best selling drug, reported fourth-quarter profit on Friday that beat Wall Street estimates on strong sales for its blockbuster drug Humira.
Keep Reading →
January 26 - Market Movers, News - Comments
Curious to know which treatments are among the 15 bestselling most profitable drugs of all time? The pharmaceutical industry has been a topic of interest for investors, market...
Keep Reading →
November 24 - News - Comments
The top 10 largest pharmaceutical companies by revenue in 2017 are leading companies that have a large geographical presence, loyal customer base and technologically advanced ...
Keep Reading →
November 23 - News - Comments
If you're seeking to invest in stocks with great long-term potential and are interested in adding some exposure to the healthcare sector, then the 15 biggest healthcare companies...
Keep Reading →
July 6 - News - Comments
You probably haven't heard of Alex Denner's Sarissa Capital Management, which is a shame, as the fund is coming off a first-quarter in which its stock picks in companies valued...
Keep Reading →
May 16 - Hedge Fund Analysis, Hedge Funds, News - Comments
Let’s focus on the 10 most advanced technologies in the world today, to highlight the great job done by our scientists and innovators.
Keep Reading →
April 5 - Lists, News - Comments
Two patents that AbbVie Inc (NYSE:ABBV) held on Humira, a treatment for arthritis, have been invalidated by an English court.
Keep Reading →
March 6 - News, Stock Analysis - Comments
The AbbVie Inc (NYSE:ABBV) board of directors has given the authorization required to increase $5 billion to the company’s existing share buyback program.
Keep Reading →
February 21 - News, Stock Analysis - Comments
The National Institute for Health and Care Excellence has refused to authorize AbbVie Inc (NYSE:ABBV)'s Venclyxto on NHS.
Keep Reading →
February 16 - News, Stock Analysis - Comments
AbbVie Inc (NYSE:ABBV) just announced that it has picked up approval for one of its lead development candidates, but the company has failed to really move on the announcement.
Keep Reading →
January 20 - News, Stock Analysis - Comments
Yes, you read the title right there are at least 12 health benefits of medical marijuana according to publicly traded weed companies.
Keep Reading →
January 12 - Lists, News - Comments
AbbVie Inc (NYSE:ABBV) has sought a joint venture with its target discovery portfolio company, Emergent Technologies Inc, Pure MHC.
Keep Reading →
January 10 - News, Stock Analysis - Comments
A Vermont drug price transparency bill threatens to make it hard for drug makers to increase drug prices without explanations.
Keep Reading →
January 3 - News, Stock Analysis - Comments
Stanley Druckenmiller was one of the fund managers for the Quantum Fund founded by George Soros.
Keep Reading →
December 23 - Dividend Stocks, Hedge Funds, News - Comments
A New Drug Application (NDA) by AbbVie Inc (NYSE:ABBV) that will be used for the treatment of Hepatitis C is at the mercy the U.S. Food and Drug Administration.
Keep Reading →
December 21 - News, Stock Analysis - Comments
Larry Robbins’ Glenview Capital Management reported an equity portfolio worth over $13.98 billion in its latest 13F filing.
Keep Reading →
December 16 - Hedge Funds, News - Comments
Larry Robbins is a billionaire investor and businessman who founded the New York-based hedge fund Glenview Capital in 2000. Mr.
Keep Reading →
December 2 - Hedge Fund Analysis, Hedge Funds, News - Comments
Gilead Sciences, Inc. (NASDAQ:GILD) might as well have quashed rumors making waves claiming it is planning to acquire Belgium-based Galapagos NV (ADR) (NASDAQ:GLPG).
Keep Reading →
November 29 - News, Stock Analysis - Comments
The final ‘stock considerations’ post of 2016 is finally at hand.
Keep Reading →
November 28 - Dividend Stocks, News, Stock Analysis - Comments
The US Patent and Trademark Office (USPTO) Patent Trial and Appeal Board (PTAB) has decided not to embark on the review of the 166 formulation patent of AbbVie Inc (NYSE:ABBV) ...
Keep Reading →
November 9 - News - Comments
AbbVie Inc (NYSE:ABBV) and Coherus Biosciences Inc (NASDAQ:CHRS) were both off to a relatively normal start in the market today.
Keep Reading →
November 7 - Market Movers, News, Stock Analysis - Comments
As we near the home stretch of 2016 it seems like Mr. Market wants to give us some better buying opportunities compared to the recent months that have passed.
Keep Reading →
November 1 - Dividend Stocks, News, Stock Analysis - Comments
Among the stocks that are capturing investors' attention today are Nordstrom, Inc. (NYSE:JWN), AbbVie Inc (NYSE:ABBV), AutoNation, Inc.
Keep Reading →
October 31 - Market Movers, News - Comments
I usually look at dividend growth stocks and their dividend increases every week, as part of my portfolio monitoring process.
Keep Reading →
October 31 - Dividend Stocks, News, Stock Analysis - Comments
I always end my ‘Recent Buys’ posts with the caveat that Mr. Market can always spring up some new opportunities not outlined in my monthly considerations posts.
Keep Reading →
October 31 - Dividend Stocks, News - Comments
Although the fundamental prospects for many companies are strong given the robust U.S.
Keep Reading →
September 6 - Market Movers, News - Comments
AbbVie Inc (NYSE:ABBV) and Biogen Inc (NASDAQ:BIIB) drug Zinbryta was approved by the Food and Drug Administration (FDA) as a therapy for adults suffering from relapsing forms...
Keep Reading →
August 26 - News, Stock Analysis - Comments
The Nasdaq and all other major indexes are in the red this morning despite tech heavyweights Amazon.com, Inc.
Keep Reading →
July 29 - Earnings Report, Market Movers, News - Comments
The financial markets today are filled with sand traps and water hazards; lower for longer crude oil prices, negative interest rate policies (NIRP), slow economic growth, the ...
Keep Reading →
June 29 - Dividend Stocks, News, Stock Analysis - Comments
After opening flat, the three indexes have sold off again. The Dow, S&P and NASDAQ are each off around 0.6%, while crude futures are down twice as much to hover just above $48...
Keep Reading →
June 14 - News - Comments
Markets are trading higher on Monday, as HSBC Holdings PLC said in a report earlier today that the markets are poised to remain bullish.
Keep Reading →
June 6 - Market Movers, News - Comments
Oil baron and America's first billionaire John D.
Keep Reading →
May 28 - Dividend Stocks, Hedge Funds, News - Comments
Larry Robbins' Glenview Capital has been underperforming the broader market and the overall hedge fund industry for over a year now.
Keep Reading →
May 20 - Hedge Fund Analysis, Hedge Funds, News - Comments
While several hedge funds have suffered enormous losses this year due to their investments in biotech stocks, the performance of the leading biotech-focused hedge fund Baker Bros...
Keep Reading →
May 7 - Hedge Fund Analysis, Hedge Funds, News - Comments
The markets are trading in the red today after investor sentiment was dented following the Labor Department's assertion that the U.S economy inched up by 0.5% in the first quarter...
Keep Reading →
April 28 - Market Movers, News - Comments
Syracuse University graduate Richard L. Haydon named his fund after the Tipperary Hill area, his childhood neighborhood.
Keep Reading →
April 26 - Hedge Fund Analysis, Hedge Funds, News - Comments
